Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy.

Freddy CalderaStacey RolakFrancis A FarrayeBrian M NecelaDavitte CogenEmily E ZonaTrevor L SchellOscar Ramirez RamirezMazen AlmasryKelly ChunMary S HayneyKeith L Knutson

Published in: Clinical and translational gastroenterology (2024)

A third dose of a COVID-19 vaccine boosts CMIR, and the response is sustained in patients with IBD.

Keyphrases

coronavirus disease
patients with inflammatory bowel disease
sars cov
immune response
rheumatoid arthritis
cell therapy
single cell
respiratory syndrome coronavirus
ulcerative colitis
smoking cessation
replacement therapy